Status:

UNKNOWN

Effects of Different Genetic Mutations on Prognosis in sMPLC Adenocarcinoma Patients

Lead Sponsor:

The First Hospital of Jilin University

Conditions:

Gene Mutation

Eligibility:

All Genders

18-75 years

Brief Summary

In 2007 and 2013, the American College of Chest Physicians (ACCP) guidelines applied the diagnostic criteria of sMPLC (synchronous multiple primary lung cancers), and the diagnostic criteria of Martin...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Male or female patients: 18-75 years old;
  • ECOG score: 0-1;
  • At least two tumors in patients with invasive lung adenocarcinoma at stage I are pathologically confirmed after sMPLC surgery;
  • Genetic test is performed on the pathological tissues of the tumor lesions excised, and at least one with driver gene;
  • Predicted survival ≥1 year;
  • No more than 3 months after sMPLC surgery (last operation);
  • Good compliance, family members agree to cooperate to receive survival follow-up;
  • Understand and voluntarily sign the informed consent.
  • Exclusion criteria:
  • Previous or co-existing malignant tumors (patients with resected basal cell carcinoma or other carcinoma in situ are not included);
  • Systemic anti-tumor therapy, including chemotherapy, radiotherapy or targeted therapy (including but not limited to monoclonal antibodies, small-molecule tyrosine kinase inhibitors, etc.) was used before enrollment.
  • Participated in clinical trials of other drugs within 4 weeks
  • All the mutations are insignificant to lung cancer;
  • The investigator is not sure that the subject will be able to complete the study ( management reasons or others).

Exclusion

    Key Trial Info

    Start Date :

    April 22 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 30 2024

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT03764371

    Start Date

    April 22 2019

    End Date

    March 30 2024

    Last Update

    October 14 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The first hospital of Jilin University

    Changchun, Jilin, China